• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Lifestyle

CJ OnStyle and CJ OnCubating See Transaction Volume Increase 16-Fold in Three Years

CJ OnStyle’s brand incubation program, CJ ONCUBATING, is drawing attention. This is because CJ ONCUBATING is not only discovering promising brands but also driving their actual growth. CJ OnStyle i…
  • 2026-08-13 08:34:26
  • SHIN MIN JOON
Lifestyle

SILICON 2 Co.,Ltd., a 'K-Beauty Distributor,' Reports Improved Revenue and Profitability in the Second Quarter

SILICON 2 Co.,Ltd. posted second-quarter earnings that exceeded market expectations, driven by the K-Beauty boom. SILICON 2 Co.,Ltd.(257720)The company announced on the 12th that its consolidated oper…
  • 2026-08-12 17:03:45
  • KYUNG GYEYOUNG
Lifestyle

DongwonIndustries Reports 2nd-Quarter Operating Profit of 151.5 Billion Won… Up 13.3% Year-Over-Year

DongwonIndustries(006040)reported growth in both revenue and operating profit for the second quarter of this year compared to the same period last year. DongwonIndustries CI. (Photo courtesy of Don…
  • 2026-08-12 16:43:12
  • Kim Ji-woo
Lifestyle

AEKYUNG INDUSTRIAL Reports Record-High Second-Quarter Revenue of 194.2 Billion Won

AEKYUNG INDUSTRIAL set a new record for quarterly revenue in the second quarter by accelerating its overseas expansion. However, profitability declined as the company focused on developing new strateg…
  • 2026-08-12 16:30:38
  • KYUNG GYEYOUNG
Lifestyle

Onconic Therapeutics Inc.: Driven by Jacubo and Propelled by New Drug R&D… First-Half Revenue Up 1.5 Times, Operating Profit Up 1.7 Times

#Onconic Therapeutics Inc. recorded significant increases in both revenue and operating profit in the first half of this year as prescriptions for its proprietary, approved new drug “Zacubo” expanded.…
  • 2026-08-12 16:25:03
  • KIM JI-WAN
Lifestyle

EyeGene,Inc-Korea BMI Submits Application to the Ministry of Food and Drug Safety for Export Approval of ‘Recombinant Toxin’

EyeGene,Inc(185490)is partnering with its largest shareholder, Korea BMI, to commercialize a next-generation recombinant botulinum toxin. The company plans to accelerate its entry into the global mark…
  • 2026-08-12 14:13:01
  • YU JIN-HEE
Lifestyle

CLASSYS Inc. Reports Record-High Second-Quarter Revenue of 105.5 Billion… Surpasses 100 Billion Mark for the First Time

CLASSYS Inc.(214150)has surpassed 100 billion won in quarterly revenue for the first time since its founding, driven by growth in major global markets and the expansion of its South American operation…
  • 2026-08-12 14:11:02
  • SONG YOUNG-DOO
Lifestyle

[Notice] K-Bio Seeks Solutions for Global Expansion at 'K-Bio Deal Summit 2026'

Edaily’s premium bio content service, “FarmEdaily,” will host the “Edaily K-Bio Deal Summit 2026” on September 9. The event, themed “K-Bio: Global Success Strategies Through Innovation,” will take pla…
  • 2026-08-12 13:31:02
  • YU JIN-HEE
Lifestyle

KT&G Corporation to Recruit New Graduates and Experienced Professionals… Open Recruitment to Be Held in the Second Half of the Year

KT&G Corporation is setting out to secure talent to drive its overseas business and future growth engines. #KT&G Corporation announced on the 12th that it is accepting applications for its open recrui…
  • 2026-08-12 10:32:22
  • kim mi-kyung
Lifestyle

"From Latte to Ice Cream"... NamyangDairyProducts Expands Uses for "Danpat Emong"

NamyangDairyProducts(003920)has launched a special set that allows consumers to enjoy “Danpat E-Mong” in a variety of ways—such as lattes and ice cream—rather than just as a drink, aiming to capture s…
  • 2026-08-12 09:49:28
  • Kim Ji-woo
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English